0001873404-25-000002.txt : 20250630 0001873404-25-000002.hdr.sgml : 20250630 20250630122406 ACCESSION NUMBER: 0001873404-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250630 DATE AS OF CHANGE: 20250630 EFFECTIVENESS DATE: 20250630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Savanna Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001873404 ORGANIZATION NAME: EIN: 853134170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-550314 FILM NUMBER: 251090217 BUSINESS ADDRESS: STREET 1: C/O UNIVERSITY LAB PARTNERS, CURIE HALL STREET 2: 1 UNIVERSITY DRIVE CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 716-969-2573 MAIL ADDRESS: STREET 1: C/O UNIVERSITY LAB PARTNERS, CURIE HALL STREET 2: 1 UNIVERSITY DRIVE CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: NovoGlia, Inc. DATE OF NAME CHANGE: 20210719 D 1 primary_doc.xml X0708 D LIVE 0001873404 Savanna Biotherapeutics, Inc. C/O UNIVERSITY LAB PARTNERS, CURIE HALL 1 UNIVERSITY DRIVE ALISO VIEJO CA CALIFORNIA 92656 716-969-2573 DELAWARE NovoGlia, Inc. Corporation true 2020 Robert Spitale c/o University Lab Partners, Currie Hall 1 University Drive Aliso Viejo CA CALIFORNIA 92656 Executive Officer Director Jeffrey W. Bird 755 Page Mill Road, Suite A-200 Palo Alto CA CALIFORNIA 94304 Director Keith Loebner 755 Page Mill Road, Suite A-200 Palo Alto CA CALIFORNIA 94304 Director Kim Kamdar 335 Old Mill Road Nissequogue NY NEW YORK 11780 Director Biotechnology Decline to Disclose 06b false 2025-06-12 true true false 0 59999993 12999997 46999996 false 30 0 0 0 false Savanna Biotherapeutics, Inc. /s/ Robert Spitale Robert Spitale Chief Executive Officer 2025-06-28